EQUITY	3 Months Ended
Mar. 31, 2026
Equity [Abstract]
EQUITY	6. EQUITY Issuance of Common Stock On January 21, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 3,333,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were approximately $500,000. On February 6, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 555,556 shares of the Company’s common stock at a price of $0.18 per share. The aggregate proceeds to the Company were approximately $100,000. On January 13, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 1,033,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were approximately $155,000.

The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/718/tableOfContent

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Name:	us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration